On Tuesday, Zimmer Biomet Holdings Inc. (NYSE:ZBH) shares advanced more than 3% after receiving a bullish rating. Loop Capital initiated coverage of ZBH with a buy rating, assigning a price target of $165 per share. The PT implies an upside potential of more than 30% based on the ZBH price of $129.26 per share as of this writing.
The firm cited the easing covid situation whilst also lauding the improving momentum from the ROSA robot. Analyst Jason Wittes also said the planned spin-off of the underperforming spine dental, as announced earlier this year, will drive growth.
Are you looking for fast-news, hot-tips and market analysis?
Sign-up for the Invezz newsletter, today.
The Spin-off of the new company called ZimVie is expected to complete in mid-2022.
Zimmer Biomet shares have plunged by nearly 50% since rallying to trade at a new 52-week high of $180 at the end of April. The stock is now down 15.57% this year.
From an investment perspective, Zimmer Biomet shares trade at reasonable trailing 12-month and forward P/E ratios of 30.93 and 15.62, respectively. Therefore, the stock could gain the attention of value investors.
However, analysts expect its earnings per share to plummet by more than 117% this year, before bouncing back by 8.48% next year. As a result, it may not be an ideal option for long-term growth investors.
Technically, Zimmer Biomet shares seem to have recently completed an upward breakout from a descending channel formation, preventing the stock from dropping deeper into oversold conditions.
Therefore, investors could target short-term profits at about $134.66, or higher at $140.52, while $124.51 and $119.55 are crucial support levels.
To invest simply and easily, users need a low-fee broker with a track record of reliability. The following brokers are highly rated, recognised worldwide, and safe to use:
There is good reason to be afraid. Previous down markets have seen declines in excess…
United Parcel Service, Inc. (NYSE:UPS) and FedEx Corporation (NYSE:FDX) are two robust logistics companies. Both…
Canadian crypto mining firm Bitfarms sold roughly $62 million worth of Bitcoin (BTC) in June,…
Invezz does not provide financial advice. Our aim is to simplify information about investing, enabling…
Noma, a Japanese film studio, has announced that it is producing three feature films that…
Bitcoin (BTC) saw continued strength on June 21 as Wall Street trading opened with a…